Variant report
Variant | nsv978937 |
---|---|
Chromosome Location | chr2:99590098-99612582 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544168518 | chr2:99604852-99604853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563281690 | chr2:99604880-99604881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529131701 | chr2:99604927-99604928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139147055 | chr2:99604934-99604935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367915106 | chr2:99604935-99604936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373258392 | chr2:99604970-99604971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542506940 | chr2:99604983-99604984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559491647 | chr2:99605005-99605006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371728309 | chr2:99605022-99605023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562670494 | chr2:99605118-99605119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551460272 | chr2:99605124-99605125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571337811 | chr2:99605136-99605137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530554583 | chr2:99605137-99605138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs75094534 | chr2:99605151-99605152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376278663 | chr2:99605170-99605171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs77531336 | chr2:99605178-99605179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550574136 | chr2:99605193-99605194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78523576 | chr2:99605205-99605206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370316425 | chr2:99605216-99605217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs78104052 | chr2:99605219-99605220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13422604 | chr2:99605230-99605231 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs553348453 | chr2:99605233-99605234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192512628 | chr2:99605238-99605239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116896058 | chr2:99605252-99605253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559770060 | chr2:99605259-99605260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575321899 | chr2:99605262-99605263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570790471 | chr2:99605272-99605273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs71435100 | chr2:99605288-99605289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544229510 | chr2:99605289-99605290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527381407 | chr2:99605292-99605293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573640975 | chr2:99605293-99605294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375678360 | chr2:99605297-99605298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368279727 | chr2:99605298-99605299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559340344 | chr2:99605306-99605307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370552655 | chr2:99605309-99605310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544842928 | chr2:99605310-99605311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565000414 | chr2:99605314-99605315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530618432 | chr2:99605345-99605346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550635951 | chr2:99605366-99605367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567279731 | chr2:99605392-99605393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7601614 | chr2:99605399-99605400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547290364 | chr2:99605400-99605401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567016710 | chr2:99605430-99605431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539258133 | chr2:99605446-99605447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558707464 | chr2:99605449-99605450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569057933 | chr2:99605473-99605474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537942238 | chr2:99605474-99605475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554603320 | chr2:99605485-99605486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184696212 | chr2:99605497-99605498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540237079 | chr2:99605518-99605519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21509527 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:99604800-99607000 | Weak transcription | Right Atrium | heart |
2 | chr2:99611400-99611600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |